Humana (NYSE:HUM) Stock Price Up 0.1%

Humana Inc. (NYSE:HUM) shares rose 0.1% on Monday . The stock traded as high as $322.89 and last traded at $320.75. Approximately 336,794 shares were traded during mid-day trading, a decline of 83% from the average daily volume of 1,972,597 shares. The stock had previously closed at $320.54.

Wall Street Analysts Forecast Growth

HUM has been the topic of several research analyst reports. Truist Financial reissued a “hold” rating and issued a $550.00 price objective on shares of Humana in a research report on Friday, January 19th. Cantor Fitzgerald lowered their price target on shares of Humana from $391.00 to $360.00 and set a “neutral” rating on the stock in a research report on Thursday, April 25th. Raymond James began coverage on shares of Humana in a research report on Friday, March 22nd. They set a “market perform” rating on the stock. Bank of America reaffirmed a “neutral” rating and set a $342.00 price target (down from $470.00) on shares of Humana in a research report on Tuesday, April 2nd. Finally, Oppenheimer decreased their target price on shares of Humana from $415.00 to $370.00 and set an “outperform” rating on the stock in a report on Thursday, April 25th. Eleven investment analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $424.50.

Humana Stock Down 0.2 %

The stock has a market cap of $39.06 billion, a price-to-earnings ratio of 20.18, a P/E/G ratio of 1.86 and a beta of 0.49. The company has a current ratio of 1.67, a quick ratio of 1.67 and a debt-to-equity ratio of 0.77. The stock’s 50-day moving average price is $323.08 and its 200-day moving average price is $385.94.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, April 24th. The insurance provider reported $7.23 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.12 by $1.11. The firm had revenue of $29.61 billion for the quarter, compared to the consensus estimate of $28.52 billion. Humana had a net margin of 1.82% and a return on equity of 17.76%. The company’s revenue for the quarter was up 10.7% on a year-over-year basis. During the same quarter in the previous year, the company earned $9.38 EPS. On average, sell-side analysts expect that Humana Inc. will post 16.18 earnings per share for the current year.

Humana Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be given a $0.885 dividend. The ex-dividend date of this dividend is Friday, June 28th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.09%. Humana’s dividend payout ratio (DPR) is currently 22.04%.

Insider Activity

In related news, Director Jorge S. Mesquita acquired 545 shares of the stock in a transaction dated Tuesday, February 20th. The stock was bought at an average price of $367.09 per share, for a total transaction of $200,064.05. Following the purchase, the director now directly owns 2,578 shares of the company’s stock, valued at approximately $946,358.02. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.29% of the stock is currently owned by company insiders.

Institutional Trading of Humana

A number of hedge funds and other institutional investors have recently bought and sold shares of HUM. Stratos Wealth Partners LTD. boosted its holdings in Humana by 4.2% during the 3rd quarter. Stratos Wealth Partners LTD. now owns 1,294 shares of the insurance provider’s stock worth $630,000 after acquiring an additional 52 shares during the last quarter. Brown Advisory Inc. boosted its holdings in Humana by 17.3% during the 3rd quarter. Brown Advisory Inc. now owns 2,311 shares of the insurance provider’s stock worth $1,124,000 after acquiring an additional 341 shares during the last quarter. Advisor Partners II LLC boosted its holdings in Humana by 9.8% during the 3rd quarter. Advisor Partners II LLC now owns 5,153 shares of the insurance provider’s stock worth $2,507,000 after acquiring an additional 459 shares during the last quarter. Park Avenue Securities LLC purchased a new position in Humana during the 3rd quarter worth $1,889,000. Finally, Catalyst Financial Partners LLC purchased a new position in Humana during the 3rd quarter worth $209,000. Institutional investors own 92.38% of the company’s stock.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.